. 2018 Jul 25;3(5):e000349. doi: 10.1136/esmoopen-2018-000349
© European Society for Medical Oncology 2018. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Figure 2.
Mean levels of Ang-2 in control and case groups. Ang-2, angiopoietin-2.